Is the cure for osteoarthritis hiding in your blood?

A company called Cytonics is attempting to change the biology of osteoarthritis — a $560 billion market where every existing treatment does nothing but manage symptoms while the cartilage keeps deteriorating.

Cytonics discovered that your blood contains a protein designed to protect your joints from the enzymes that destroy cartilage. Your body just doesn't produce enough of it. So they engineered a synthetic version that can be mass-produced.

More than 10,000 patients have been treated with their first-generation therapy. The new version — 200% more potent — just cleared Phase 1 human safety trials with zero adverse events.

If it works, this would be the first disease-modifying osteoarthritis treatment in history. The first one. Ever.

You can see the full details — and invest — by clicking here.

Disclaimer: This is a paid advertisement for Cytonics Regulation CF offering. Please read the offering circular at https://invest.cytonics.com. Forward-looking statements are subject to risks and uncertainties. There is no guarantee of performance. Past performance does not predict future results. All investments involve risk, including loss of principal.